Search - tctmd.com

Displaying 221 - 240 of 265

Sort: Relevancy | Date

Presentation TCT 2015

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Presenter: Thomas Engstroem, Barry D. Rutherford, Colin Berry

October 11, 2015

Presentation TCT 2015

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Presenter: Thomas Engstroem, Barry D. Rutherford, Anthony H. Gershlick

October 11, 2015

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

Presentation TCT 2015

Keynote Lecture: What It Was Like to Discover the Stent: A Personal Journey

Presenter: Marvin L. Woodall, Julio C. Palmaz

October 11, 2015

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

The Long Road to a Shorter Door-to-Balloon Time

September 16, 2014

Presentation TCT 2014

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Ricardo Sanz-Ruiz, MD

September 15, 2014

Presentation TCT 2014

Side Cell Population and Valve Function

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Muralidhar Padala

September 15, 2014

Presentation TCT 2014

Enhancement of MSC Function by Chronic Exposure to Hypoxia

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Stephen E. Epstein

September 15, 2014

Presentation TCT 2014

Cellular Nanotechnology in STEMI

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Jonathan Leor

September 15, 2014

Presentation TCT 2014

Direct Flow Medical - Technology Review, Clinical Results (DISCOVER), Case Examples, and Status of the US Clinical Trial

Presenter: E. Murat Tuzcu

September 15, 2014

Presentation TCT 2014

Microvesicles: Multiple Effects of Cord-Blood CD133+ Cells

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Wojtek Wojakowski

September 15, 2014

Presentation TCT 2014

Cell Matrix and Endothelial Function: Impact of Hyperglycemia

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Elazer R. Edelman

September 15, 2014

Presentation TCT 2014

Enhanced Effects of Primed Peripheral Monocytes

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Hyo-Soo Kim

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

Presentation TCT 2014

FFR, CFR and Microvascular Resistance: Frequency and Impact of Discordances

Presenter: Justin E. Davies, Allen Jeremias, Nick E. J. West, Tim P. van de Hoef

September 14, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Todd Neale

September 13, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

Advertisement

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Keynote Lecture: What It Was Like to Discover the Stent: A Personal Journey

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

The Long Road to a Shorter Door-to-Balloon Time

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

Side Cell Population and Valve Function

Enhancement of MSC Function by Chronic Exposure to Hypoxia

Cellular Nanotechnology in STEMI

Direct Flow Medical - Technology Review, Clinical Results (DISCOVER), Case Examples, and Status of the US Clinical Trial

Microvesicles: Multiple Effects of Cord-Blood CD133+ Cells

Cell Matrix and Endothelial Function: Impact of Hyperglycemia

Enhanced Effects of Primed Peripheral Monocytes

COMBO Stent Achieves Neointimal Regression at 24 Months

FFR, CFR and Microvascular Resistance: Frequency and Impact of Discordances

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

OPTIMIZE: 3-Month DAPT Safe with ZES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content